{"id":2231,"date":"2024-12-30T10:15:14","date_gmt":"2024-12-30T02:15:14","guid":{"rendered":"https:\/\/aimedorig.com\/wordpress\/?p=2231"},"modified":"2024-12-30T10:15:14","modified_gmt":"2024-12-30T02:15:14","slug":"the-worlds-first-ai-designed-long-acting-glp-1-weight-loss-drug-to-be-launched-by-intelligent-medicine-original","status":"publish","type":"post","link":"https:\/\/aimedorig.com\/wordpress\/?p=2231&lang=en","title":{"rendered":"The World&#8217;s First AI-Designed Long-Acting GLP-1 Weight Loss Drug to Be Launched by Intelligent Medicine Original"},"content":{"rendered":"<p class=\"text-news1\">Intelligent Medicine Original, leveraging its proprietary AI drug design platform TranProteins, has successfully developed a GLP-1 receptor agonist (GLP-1 RA) with an extended half-life and enhanced efficacy. The next-generation GLP-1 RA boasts a half-life (T1\/2) three times longer than semaglutide, marking a significant milestone in achieving long-acting weight loss medications. This is also the world&#8217;s first AI-designed blockbuster weight loss drug.<\/p>\n<p class=\"text-news1\">Using proprietary algorithms, Intelligent Medicine Original designed over tens of thousands of novel GLP-1 RA protein peptide sequences. Through its independently developed high-efficiency screening process, three candidate peptide drugs were successfully identified, followed by animal efficacy and pharmacokinetics studies.<\/p>\n<p class=\"text-news1\">The AI-powered high-throughput drug design and screening capabilities of TranProteins have significantly shortened the drug design cycle and greatly improved the success rate of drug development. These experimental results, achieved within a single experimental cycle, further validate Intelligent Medicine Original\u2019s technological leadership in protein drug design. Its proprietary protein design methods can also be broadly applied to the development of other protein-based drugs, providing strong support for innovative drug research and development.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Intelligent Medicine Original, leveraging its proprieta [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","footnotes":""},"categories":[85,87],"tags":[],"class_list":["post-2231","post","type-post","status-publish","format-standard","hentry","category-_eng","category-industry_information_eng"],"blocksy_meta":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/aimedorig.com\/wordpress\/index.php?rest_route=\/wp\/v2\/posts\/2231"}],"collection":[{"href":"https:\/\/aimedorig.com\/wordpress\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aimedorig.com\/wordpress\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aimedorig.com\/wordpress\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aimedorig.com\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2231"}],"version-history":[{"count":1,"href":"https:\/\/aimedorig.com\/wordpress\/index.php?rest_route=\/wp\/v2\/posts\/2231\/revisions"}],"predecessor-version":[{"id":2232,"href":"https:\/\/aimedorig.com\/wordpress\/index.php?rest_route=\/wp\/v2\/posts\/2231\/revisions\/2232"}],"wp:attachment":[{"href":"https:\/\/aimedorig.com\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aimedorig.com\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aimedorig.com\/wordpress\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}